David F Ransohoff

发表

Michael Pignone, David F Ransohoff, Louise B Russell, 2011, Medical decision making : an international journal of the Society for Medical Decision Making.

Transparent Reporting of a multivariable prediction model for Individual Prognosis Or Diagnosis (TRIPOD): Explanation and Elaboration

Gary S Collins, Karel G M Moons, Douglas G Altman, 2015, Annals of Internal Medicine.

How to decide whether a clinical practice guideline is trustworthy.

Michael Pignone, David F Ransohoff, D. Ransohoff, 2013, JAMA.

Protein-based multiplex assays: mock presubmissions to the US Food and Drug Administration.

Christopher R Kinsinger, Mehdi Mesri, Henry Rodriguez, 2010, Clinical chemistry.

Using Risk for Advanced Proximal Colonic Neoplasia To Tailor Endoscopic Screening for Colorectal Cancer

David F Ransohoff, Thomas F Imperiale, D. Ransohoff, 2003, Annals of Internal Medicine.

Overstating the evidence for lung cancer screening: the International Early Lung Cancer Action Program (I-ELCAP) study.

Peter C Gøtzsche, Steven Woloshin, David F Ransohoff, 2007, Archives of internal medicine.

Challenges and opportunities in evaluating diagnostic tests.

David F Ransohoff, D. Ransohoff, 2002, Journal of clinical epidemiology.

Are Physicians Doing Too Much Colonoscopy? A National Survey of Colorectal Surveillance after Polypectomy

David F Ransohoff, D. Ransohoff, C. Klabunde, 2004, Annals of Internal Medicine.

The process to discover and develop biomarkers for cancer: a work in progress.

David F Ransohoff, D. Ransohoff, 2008, Journal of the National Cancer Institute.

Analytical validation of protein-based multiplex assays: a workshop report by the NCI-FDA interagency oncology task force on molecular diagnostics.

Christopher R Kinsinger, Mehdi Mesri, Henry Rodriguez, 2010, Clinical chemistry.

Variation in polyp detection rates at screening colonoscopy.

David F Ransohoff, Thomas F Imperiale, D. Ransohoff, 2009, Gastrointestinal endoscopy.

Colon cancer screening models: lessons and challenges.

Michael Pignone, David F Ransohoff, D. Ransohoff, 2013, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

Gastroesophageal reflux, Barrett esophagus, and esophageal cancer: clinical applications.

David F Ransohoff, D. Ransohoff, N. Shaheen, 2002, JAMA.

Why is prostate cancer screening so common when the evidence is so uncertain? A system without negative feedback.

Floyd J Fowler, David F Ransohoff, D. Ransohoff, 2002, The American journal of medicine.

Addressing overdiagnosis and overtreatment in cancer: a prescription for change.

Sudhir Srivastava, Brian Reid, David F Ransohoff, 2014, The Lancet. Oncology.

How to improve reliability and efficiency of research about molecular markers: roles of phases, guidelines, and study design.

David F Ransohoff, D. Ransohoff, 2007, Journal of clinical epidemiology.

Gene-expression signatures in breast cancer.

David F Ransohoff, D. Ransohoff, 2003, The New England journal of medicine.

Promises and limitations of biomarkers.

David F Ransohoff, D. Ransohoff, 2009, Recent results in cancer research. Fortschritte der Krebsforschung. Progres dans les recherches sur le cancer.